BCL2 and cancer: These observations portend opportunities for exploiting endogenous transcriptional pathways for suppressing expression of antiapoptotic Bcl-2-family genes in cancer, together with the idea of employing them as chemo- or radiosensitizers, rather than relying on their antitumor activity as single agents.